In Observance of Mental Health Awareness Month, Merck Animal Health Announces Inaugural Veterinary Wellbeing Collective to
Help Advance Veterinary Wellbeing
May 4, 2026
As Featured in JAVMA, the Veterinary Wellbeing Collective Brings Together Leaders in the Space to Combat Burnout and Enhance Mental Health in the Veterinary Profession
RAHWAY, N.J., May 4, 2026 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, New Jersey, USA (NYSE:MRK), announced the Veterinary Wellbeing Collective, a collaborative initiative hosted by Merck Animal Health, to advance a unified strategy to address veterinary mental health challenges.
On July 29, 2025, Merck Animal Health hosted the inaugural Veterinary Wellbeing Collective roundtable at its headquarters in Rahway, N.J., bringing together 16 leading mental health and wellbeing experts to discuss the past, present and future of veterinary wellbeing. This inaugural event marked a shift from fragmented efforts to coordinated, evidence-based action to promote mental health and wellbeing in the veterinary profession. In a newly published peer-reviewed article, JAVMA spotlighted how the Veterinary Wellbeing Collective is working toward a coordinated approach to advance wellbeing in the profession. For more details, visit this link.
“For years, the veterinary profession has grappled with wellbeing challenges, but this Collective changes that narrative,” said Bridget Hanley, VMD, associate director, pharmacovigilance and wellbeing liaison, Merck Animal Health. “The roundtable’s open dialogues revealed how past stigmas around burnout can be transformed into proactive solutions.”
In agreement that veterinary wellbeing is essential for a sustainable profession, the roundtable identified priorities for reducing stigma, improving workplace culture and fostering systemic change. By uniting leaders and organizations, the Veterinary Wellbeing Collective is helping to move from reactive fixes to proactive, collaborative solutions that empower veterinary professionals, including creating a consensus definition of wellbeing and related terminology as well as a centralized online database to share strategies, assessments, tools and resources.
Key Information:
The Past: From Stigma to Awareness
Participants noted that pre-1990s discussions on veterinary mental health were rare, often framing issues as personal failures. Over the last decade, alarmist framing of burnout and suicide have dominated the conversation, contributing to feelings of hopelessness in finding solutions to support mental health. However, recent shifts – driven by research like the 2023 Merck Animal Health Veterinary Wellbeing Study – revealed a more positive reality: 75% of veterinarians reported career satisfaction, higher than the U.S. average, though gaps persist among young professionals, non-veterinarians and underrepresented groups.
The Present: Current Challenges and Initiative
Participants identified multi-level challenges including individual, workplace and systemic, detailing key contributing factors including, but not limited to:
Individual Level: Lack of mental health resource access, workplace incivility, grief navigation and physical demands;
Workplace Level: Lack of structured onboarding, unhealthy workplace cultures, limited leadership training and inequitable resources;
Systemic Level: Stigma, duplicative efforts, funding shortages and access-to-care barriers.
The Future: A Vision for Coordinated Action
Participants shared a vision of a stigma-free profession with strengths-based language, integrated research to support wellbeing and industry-supported prevention. Future plans include:
– Developing a consensus definition of veterinary wellbeing;
– Creating a centralized online database for resources;
– Launching a joint communications campaign for unified messaging;
– Convening virtually every two months to continue building on these efforts.
“This roundtable was a pivotal moment for veterinary wellbeing, bringing together key individuals and organizations to move beyond fragmented efforts and toward true coordination,” said corresponding author Addie Reinhard, DVM, MS, CEO of MentorVet, a Merck Animal Health partner. “By improving communication and cohesion in the veterinary wellbeing space, we can begin to address burnout and mental health challenges proactively, creating a healthier and more sustainable profession.”
FAQ:
– Q: What is the Veterinary Wellbeing Collective?
A: The Veterinary Wellbeing Collective is a collaborative group of veterinary leaders, researchers, mental health professionals and organizations dedicated to promoting a coordinated, evidence-based approach to veterinary wellbeing. It was hosted by Merck Animal Health to increase collaboration and communication and foster systemic changes to combat issues like burnout and mental health stigma in the veterinary profession.
Q: Which organizations are represented in the Veterinary Wellbeing Collective?
A: The Collective includes representatives from the following organizations:
– MentorVet
– Merck Animal Health
– International Association of Veterinary Social Work
– American Association of Veterinary Medical Colleges
– Not One More Vet
– American Veterinary Medical Association
– Brakke Consulting
– Flourish Veterinary Consulting
– Veterinary Hope Foundation
– Reviving Veterinary Medicine
– National Association of Veterinary Technicians in America
– Kent State University
– American Association of Equine Practitioners
– University of Tennessee College of Veterinary Medicine
Q: When and why was the inaugural Veterinary Wellbeing Collective roundtable held?
A: The first roundtable was hosted by Merck Animal Health on July 29, 2025, in Rahway, N.J. Its purpose was to drive actionable discussions on the past, present and future of veterinary wellbeing, bringing together 16 experts to identify priorities and reduce duplicative efforts. The event aimed to shift from individual distress mitigation to systemic, collaborative solutions for a more sustainable veterinary profession.
Q: What key insights were shared about the history of veterinary mental health?
A: Participants noted that before the 1990s, mental health discussions were rare and often viewed as personal weaknesses. In recent decades, alarmist narratives about burnout and suicide have contributed to hopelessness in finding solutions to support mental health, despite positive data from studies like the 2023 Merck Animal Health Veterinary Wellbeing Study, which showed 75% of veterinarians reporting career satisfaction – higher than the U.S. average. Recent shifts include increased investments in resources, veterinary social work and evidence-based programs.
Q: What are some of the current challenges in veterinary wellbeing identified by the Collective?
A: Some of the challenges discussed included, but were not limited to:
Individual: Lack of mental health resource access, workplace incivility, grief navigation, and physical demands;
Workplace: Poor onboarding, unhealthy workplace cultures, limited leadership training, and inequitable resources;
Systemic: Stigma, uncoordinated efforts, lack of funding for research, diversity issues, and access-to-care barriers.
These were discussed to highlight the need for coordinated action.
Q: What does the future hold for the Veterinary Wellbeing Collective?
A: The Collective envisions a stigma-free veterinary profession with strengths-based language, integrated wellbeing metrics (prioritized alongside financial ones), and industry-supported prevention efforts. Plans include creating a consensus definition of wellbeing, a centralized online database for resources and a joint communications campaign. The group plans to convene virtually every two months to continue building on these efforts.
Q: How can I get involved or learn more about veterinary wellbeing resources?
A: Contact the corresponding author, Dr. Addie Reinhard, DVM, MS, at addie@mentorvet.net for details on involvement or resources. Visit websites such as AVMA.org, NOMV.org, or MentorVet.net for programs like peer support groups, training certificates and research studies.
About The Veterinary Wellbeing Collective
The Veterinary Wellbeing Collective is a collaborative group of veterinary leaders, researchers, mental health professionals and organizations dedicated to evidence-informed strategies for mental health and wellbeing in the veterinary profession. Hosted by Merck Animal Health, it fosters coordinated action on key mental health issues across the profession.
About Merck Animal Health
Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is a global animal health business committed to The Science of Healthier Animals™. For more than 130 years, we have pioneered groundbreaking science. Today, we are driven by continuous innovation to develop breakthrough medicines, vaccines and technology. Rooted in direct experience on the farm and in the clinic, we work hand in hand with our customers every step of the way. Our singular focus is to empower those who care for animals, helping them manage their vital responsibility with confidence. Because when it comes to animal health, no one sees it like we do. For more information, visit www.merck-animal-health.com and connect with us on LinkedIn, Facebook, X (formerly Twitter) and Instagram.
Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2025 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen